Second-line chemotherapy in advanced biliary tract cancer: Who may benefit?

被引：2
|
作者：
Salati, Massimiliano
Caputo, Francesco
Marcheselli, Luigi
Rimini, Margherita
Spallanzani, Andrea
Gelsomino, Fabio
Andrikou, Kalliopi
Zironi, Sandra
Di Emidio, Katia
Clo', Vera
Luppi, Gabriele
Cascinu, Stefano
机构：
[1] Univ Hosp Modena, Dept Oncol & Hematol, Modena, Italy
[2] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy
[3] Univ Hosp Modena, Modena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
381
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Benefit of second-line chemotherapy for advanced biliary tract cancer.
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Bezan, Angelika
    Rossmann, Christopher
    Szkandera, Joanna
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    Catalano, V.
    Graziano, F.
    Santini, D.
    D'Emidio, S.
    Baldelli, A. M.
    Rossi, D.
    Vincenzi, B.
    Giordani, P.
    Alessandroni, P.
    Testa, E.
    Tonini, G.
    Catalano, G.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (09) : 1402 - 1407
  • [3] Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    V Catalano
    F Graziano
    D Santini
    S D'Emidio
    A M Baldelli
    D Rossi
    B Vincenzi
    P Giordani
    P Alessandroni
    E Testa
    G Tonini
    G Catalano
    [J]. British Journal of Cancer, 2008, 99 : 1402 - 1407
  • [4] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Second-line FOLFOX chemotherapy for advanced biliary tract cancer
    Brandi, Giovanni
    Frega, Giorgio
    Rizzo, Alessandro
    [J]. LANCET ONCOLOGY, 2021, 22 (07): : E285 - E285
  • [6] Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
    Florian Moik
    Jakob M. Riedl
    Thomas Winder
    Angelika Terbuch
    Christopher H. Rossmann
    Joanna Szkandera
    Thomas Bauernhofer
    Anne-Katrin Kasparek
    Renate Schaberl-Moser
    Andreas Reicher
    Felix Prinz
    Martin Pichler
    Herbert Stöger
    Michael Stotz
    Armin Gerger
    Florian Posch
    [J]. Scientific Reports, 9
  • [7] Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Terbuch, Angelika
    Rossmann, Christopher H.
    Szkandera, Joanna
    Bauernhofer, Thomas
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Reicher, Andreas
    Prinz, Felix
    Pichler, Martin
    Stoeger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] Benefit of second-line chemotherapy in patients with advanced biliary tract cancer: A propensity score analysis
    Thanasombunsukh, Kijjakom
    Khorana, Jiraporn
    Tantraworasin, Apichat
    Charoentum, Chaiyut
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S496 - S496
  • [9] SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES
    Brungs, Daniel
    Aghmesheh, Morteza
    Sjoquist, Katrin
    Goldstein, David
    [J]. Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 168 - 168
  • [10] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345